Efficacy and safety of baricitinib in patients with rheumatoid arthritis and inappropriate response to conventional disease-modifying anti-rheumatic drugs: 24-week phase 3 RA-BUILD study summary results
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY（2016）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined